SenesTechSNES
SNES
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
10.52% less ownership
Funds ownership: 11.04% [Q3] → 0.52% (-10.52%) [Q4]
25% less funds holding
Funds holding: 4 [Q3] → 3 (-1) [Q4]
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
88% less capital invested
Capital invested by funds: $148K [Q3] → $17.7K (-$130K) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for SNES.
Financial journalist opinion
Based on 5 articles about SNES published over the past 30 days
Neutral
PRNewsWire
1 day ago
SenesTech to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025
PHOENIX , March 31, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in fertility control solutions for managing rodent populations, today announced that it will participate in a webcast fireside chat at the Lytham Partners 2025 Industrials & Basic Materials Investor Summit, taking place virtually on Tuesday, April 1, 2025. The fireside chat will take place at 3:00 p.m.
Neutral
Seeking Alpha
2 weeks ago
SenesTech, Inc. (SNES) Q4 2024 Earnings Call Transcript
SenesTech, Inc. (NASDAQ:SNES ) Q4 2024 Earnings Conference Call March 12, 2025 5:00 PM ET Company Participants Robert Blum – Lytham Partners Joel Fruendt – Chief Executive Officer Tom Chesterman – Chief Financial Officer Conference Call Participants Sameer Joshi – H.C. Wainwright Operator Good day, and welcome to the SenesTech Fourth Quarter and Fiscal Year 2024 Financial Results Conference Call.
Neutral
PRNewsWire
2 weeks ago
SenesTech Announces Record Fourth Quarter and Full Year 2024 Financial Results with 70% Quarterly Revenue Growth; Gross Profit Margins of 61%; Reduction in Operating Expenses; and Dramatic Improvement in Adjusted EBITDA
Company announces new operating optimization initiatives to reduce expenses by approximately $2 million to accelerate path to profitability PHOENIX , March 12, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in fertility control solutions for managing rodent populations, today announced fourth quarter and full year 2024 financial results. Q4 2024 Highlights Revenue increased 70% to $501,000 in Q4 2024 compared to $295,000 in Q4 2023, led by growth in e-commerce which increased 206%.
Neutral
PRNewsWire
3 weeks ago
SenesTech Announces Warrant Exercise for $1.1 Million in Gross Proceeds
PHOENIX , March 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in fertility control solutions for managing rodent populations, announced today the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 374,718 shares of the Company's common stock originally issued by the Company on August 23, 2024, each having an original exercise price of $4.35 per share, at a reduced exercise price of $2.90 per share. In addition, the Company will issue new short-term warrants, as described below.
Neutral
PRNewsWire
3 weeks ago
SenesTech to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Wednesday, March 12, 2025
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX , March 6, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its fourth quarter and fiscal year 2024, ended December 31, 2024, after the market close on Wednesday, March 12, 2025. The Company has scheduled a conference call that same day, Wednesday, March 12, 2025, at 5:00 pm ET, to review the results.
Neutral
PRNewsWire
1 month ago
SenesTech Expands its Rapidly Growing Global Footprint and Clears Major Regulatory Hurdle, Paving the Way for Use in Australia and New Zealand
SenesTech and Distribution Partner to Bring Evolve™ to New Zealand's Predator Free 2050 Initiative PHOENIX , Feb. 25, 2025 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions for managing rodent populations, is pleased to announce a significant milestone in its expansion into vast and largely untapped markets for rodent fertility control across New Zealand and Australia. In partnership with Evicom, a provider of environmental consulting, on-ground environmental management and wildlife control and management services across Australia and New Zealand, SenesTech is bringing Evolve™ Rat and Evolve™ Mouse to the forefront of integrated pest management (IPM) solutions in the region.
Neutral
PRNewsWire
1 month ago
SenesTech Expands into Warehousing and Distribution Sector with Multi-Pallet Initial Shipment of Evolve Rodent Birth Control™
PHOENIX, Ariz. , Feb. 18, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech"), a pioneer in humane rodent pest control solutions, is pleased to announce the shipment of a substantial order of its Evolve™ Rodent Birth Control product to one of the largest warehousing and distribution companies in the Midwest.
Neutral
PRNewsWire
1 month ago
SenesTech Expands E-Commerce Presence with Evolve Rodent Birth Control™ Now Available on TractorSupply.com
PHOENIX , Feb. 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech"), a pioneer in humane rodent pest control solutions, is pleased to announce that its Evolve™ Rodent Birth Control product line is now available for purchase on TractorSupply.com. This expansion represents another key milestone in SenesTech's e-commerce growth strategy, bringing its innovative and effective rodent control solution to a broader customer base nationwide.
Neutral
PRNewsWire
1 month ago
SenesTech Expands Global Footprint for Evolve Rodent Birth Control™: Signs Letter of Intent with SMark to Enter Indian Rodent Pest Control Market
PHOENIX , Feb. 4, 2025 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in humane pest control solutions, is pleased to announce its plans to enter the Indian rodent pest control market through a partnership with SMark, a well-established distributor based in India. The partnership is cemented by a recently signed letter of intent, underscoring the shared commitment to bringing innovative, non-lethal rodent control solutions to this rapidly growing market.
Neutral
PRNewsWire
2 months ago
Baltimore Adopts Evolve™ Rodent Birth Control for Integrated Pest Management Targeting Rodent Overpopulation
Identifies Population Control as a Humane, Effective Solution for Winning the War Against Rats PHOENIX , Jan. 21, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in innovative pest control solutions, is pleased to announce that the City of Baltimore has begun integrating Evolve™, SenesTech's cutting-edge rodent birth control product, into the city's rodent management programs. This marks a pivotal step in Baltimore's efforts to address its significant rodent population, a challenge highlighted by a recent ranking of Baltimore as one of America's "rattiest cities.
Charts implemented using Lightweight Charts™